Le Lézard
Classified in: Health, Science and technology

3Lions Publishing, Inc. Announces Release 2.5 of ExpressoŽ: Breach Notification Wizard


TAMPA, Fla., Sept. 23, 2019  3Lions Publishing, Inc. (3LP), the owner/operator of the HIPAA Survival Guide, is pleased to announce Release 2.5 of ExpressoŽ featuring our Breach Notification Wizard. ExpressoŽ 2.5 is available for purchase on the HIPAA Survival Guide Store as part of our HIPAA Compliance Subscription Plan. ExpressoŽ is our software-as-a-service offering which embodies the NIST seven (7) step process for performing Risk Assessments and is now poised to save our customers hundreds of person hours by identifying when Breach Notification is triggered and gathering the requisite information necessary to Notify stakeholders under applicable Federal/State law.

Our Wizard contains a Jurisdictions table that enables you to quickly determine the Notification requirements of all U.S. States/Territories that may have been impacted by the Breach. It also performs the necessary "Notification math" that determines when HHS is notified, depending on how many patients were impacted across Jurisdictions and when "major media" is notified, depending on how many patients were impacted within a Jurisdiction.

Carlos Leyva, CEO of 3Lions Publishing, Inc., says: "What QuickBooks Online ("QBO") did for accounting ExpressoŽ 2.5 does for Risk Assessments and Breach Notification. QBO did not eliminate all the work associated with accounting, however it transformed accounting from a necessary evil, something to be avoided at all costs and/or handed over to a third party, to something that a business person could master at some basic to intermediate level. With the Release of ExpressoŽ 2.5 3Lions continues to deliver on the promise of Enterprise Compliance for the Masses."

Covered entities no longer need to fear willful neglect for lack of visible, demonstrable evidence of a Risk Assessment. Further, our Wizard, together with our Breach Notification Framework and our Breach Response Framework, will save your organization tens of thousands of dollars when (not if) your organization experiences a Breach. Although ExpressoŽ does not completely obviate the need for counsel, it will save you hundreds of person-hours of billable time.

About 3Lions Publishing, Inc. (3LP)

3LP focuses on publishing online curated content within well-defined subject matter domains, such as healthcare. 3LP helps publishers leverage and monetize their content by providing a publishing platform that matches high quality content with a digital marketing centric set of audience development tools. 3LP is located in the greater Tampa, FL area.

 

SOURCE 3Lions Publishing, Inc.


These press releases may also interest you

at 08:20
In celebration of National Doctors' Day on March 30, patients across the country are sharing personal stories about how their MDVIP-affiliated primary care physician has made a difference in their life. MDVIP collected and will deliver to its network...

at 08:17
AMIGOS FOR KIDS, a Miami nonprofit organization founded in 1991, is dedicated to preventing child abuse and neglect by valuing children, strengthening families and educating communities. ...

at 08:15
Maverix Medical, a dedicated lung cancer platform established by Ajax Health, KKR, and Hologic, Inc., today announced the acquisition of Cirrus Bio for an undisclosed amount....

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...



News published on and distributed by: